Search Results - "Piedra, Patricia"
-
1
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
Published in mAbs (01-01-2009)“…Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR). Clinical trials are ongoing globally to evaluate…”
Get full text
Journal Article -
2
Farmacovigilancia intensiva de vacunas SOBERANA®02 y Soberana®Plus en población pediátrica en el Centro de Inmunología Molecular
Published in Vaccimonitor (01-09-2023)“…Las vacunas SOBERANA®02 y SOBERANA® Plus contra el coronavirus tipo 2 causante del síndrome respiratorio agudo severo, recibieron autorización de uso en…”
Get full text
Journal Article -
3
Efectividad y seguridad del uso de ior® EPOCIM en pacientes en prediálisis Ensayo clínico
Published in Revista habanera de ciencias médicas (01-12-2016)“…Introducción: El ior® EPOCIM (eritropoyetina humana recombinante), es un medicamento cubano que se produce en el Centro de Inmunología Molecular, el cual ha…”
Get full text
Journal Article -
4
Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007
Published in MEDICC review (01-07-2009)“…Introduction Nimotuzumab, developed in Cuba, is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It has been evaluated…”
Get full text
Journal Article -
5
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial
Published in Journal of Cancer (01-01-2019)“…: Nimotuzumab is a humanized anti-epidermal growth factor receptor (EGFR) antibody that has shown preclinical and clinical anticancer activity in cerebral…”
Get full text
Journal Article -
6
Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients
Published in MEDICC review (01-07-2010)“…Recombinant human erythropoietin (RHuEPO) is an erythropoiesis stimulating agent (ESA) used to treat anemia in patients with total or relative erythropoietin…”
Get full text
Journal Article -
7
Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody
Published in Hybridoma (2005) (01-08-2008)“…Scavenger receptor cysteine-rich (SRCR) domains are evolutionally conserved modules that display complex structures stabilized by key amino acids, while some…”
Get more information
Journal Article -
8
Efficacy and Safety of ior®EPOCIM for Chemotherapy- or Radiotherapy-Induced Anemia in Pediatric Cancer Patients
Published in MEDICC review (01-07-2010)Get full text
Journal Article -
9
-
10
Efectividad y seguridad del uso de ior® EPOCIM en pacientes en prediálisis Ensayo clínico
Published in Revista habanera de ciencias médicas (01-12-2016)Get full text
Journal Article -
11
Seguridad y efectividad del nimotuzumab en los pacientes con tumores gliales malignos
Published in Revista Cubana de Neurología y Neurocirugía (2015)“…OBJECTIVE: To evaluate usage patterns for nimotuzumab, safety and effectiveness in terms of survival in patients with high–grade gliomas treated in medical…”
Get full text
Journal Article -
12
Eficacia y seguridad de la eritropoyetina en la anemia de la prematuridad
Published in Revista cubana de pediatria (01-06-2013)“…Introducción: la eritropoyetina alfa recombinante forma parte del tratamiento de la anemia de la prematuridad. En Cuba su uso ha sido limitado y controvertido…”
Get full text
Journal Article